Investors Buy Large Volume of Call Options on Oscar Health (NYSE:OSCR)

Oscar Health, Inc. (NYSE:OSCR) was the recipient of some unusual options trading on Wednesday. Stock traders acquired 90,711 call options on the company. This represents an increase of 517% compared to the average daily volume of 14,701 call options.

Analyst Ratings Changes

A number of analysts have recently weighed in on OSCR shares. Wall Street Zen downgraded Oscar Health from a “buy” rating to a “hold” rating in a research report on Sunday, June 8th. Wells Fargo & Company downgraded Oscar Health from an “overweight” rating to an “equal weight” rating and dropped their price objective for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Finally, Piper Sandler dropped their price objective on Oscar Health from $25.00 to $18.00 and set an “overweight” rating for the company in a research report on Monday, June 9th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, Oscar Health presently has a consensus rating of “Hold” and an average price target of $16.50.

Oscar Health Price Performance

Shares of OSCR stock opened at $18.81 on Thursday. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.22. Oscar Health has a twelve month low of $11.20 and a twelve month high of $23.79. The company has a market cap of $4.79 billion, a P/E ratio of 67.17 and a beta of 1.73. The business has a fifty day simple moving average of $14.29 and a 200 day simple moving average of $14.48.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.83 by $0.09. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The business had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. During the same period in the prior year, the company earned $0.62 EPS. Oscar Health’s revenue for the quarter was up 42.2% on a year-over-year basis. On average, sell-side analysts forecast that Oscar Health will post 0.69 EPS for the current fiscal year.

Insider Activity

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company’s stock in a transaction on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the sale, the director now directly owns 64,512 shares in the company, valued at approximately $1,059,932.16. This represents a 27.93% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 24.39% of the company’s stock.

Hedge Funds Weigh In On Oscar Health

A number of institutional investors and hedge funds have recently bought and sold shares of OSCR. Vontobel Holding Ltd. acquired a new position in Oscar Health in the 4th quarter worth about $370,000. Rhumbline Advisers increased its holdings in Oscar Health by 2.4% in the 4th quarter. Rhumbline Advisers now owns 271,227 shares of the company’s stock worth $3,645,000 after purchasing an additional 6,483 shares in the last quarter. State of New Jersey Common Pension Fund D increased its holdings in Oscar Health by 6.4% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 116,555 shares of the company’s stock worth $1,566,000 after purchasing an additional 6,965 shares in the last quarter. Alberta Investment Management Corp acquired a new position in Oscar Health in the 4th quarter worth about $138,000. Finally, Ieq Capital LLC acquired a new position in Oscar Health in the 4th quarter worth about $203,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.